J. Goldman & Co’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,155
| Closed | -$172K | – | 383 |
|
|
2022
Q1 | $172K | Hold |
2,155
| – | – | 0.01% | 234 |
|
|
2021
Q4 | $439K | Buy |
+2,155
| New | +$439K | 0.02% | 218 |
|
|
2021
Q3 | – | Sell |
-5,808
| Closed | -$1.51M | – | 386 |
|
|
2021
Q2 | $1.51M | Buy |
5,808
+4,380
| +307% | +$1.14M | 0.06% | 201 |
|
|
2021
Q1 | $551K | Sell |
1,428
-1,234
| -46% | -$476K | 0.02% | 267 |
|
|
2020
Q4 | $1.11M | Sell |
2,662
-1,658
| -38% | -$693K | 0.06% | 184 |
|
|
2020
Q3 | $1.07M | Buy |
+4,320
| New | +$1.07M | 0.07% | 153 |
|